| # | Drug | Count |
|---|---|---|
| 0 | DUPILUMAB | 10265 |
| 1 | ADALIMUMAB | 2814 |
| 2 | PREDNISONE | 2268 |
| 3 | INFLIXIMAB-DYYB | 1929 |
| 4 | INFLIXIMAB | 1695 |
| 5 | RISANKIZUMAB-RZAA | 1398 |
| 6 | METHOTREXATE SODIUM | 1387 |
| 7 | ACETAMINOPHEN | 1315 |
| 8 | METHOTREXATE | 1282 |
| 9 | SECUKINUMAB | 1153 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INFLIXIMAB-DYYB | 1929 | 0.5598 |
| 1 | EPTINEZUMAB-JJMR | 602 | 0.0617 |
| 2 | ARIPIPRAZOLE LAUROXIL | 182 | 0.0395 |
| 3 | ERGOCALCIFEROL | 965 | 0.0325 |
| 4 | ENTACAPONE | 115 | 0.0270 |
| 5 | BOTULINUM TOXIN TYPE A | 343 | 0.0268 |
| 6 | NALTREXONE | 701 | 0.0226 |
| 7 | GALCANEZUMAB-GNLM | 673 | 0.0208 |
| 8 | DUPILUMAB | 10265 | 0.0198 |
| 9 | CARBIDOPA AND LEVODOPA | 904 | 0.0191 |
| # | Drug class | Count |
|---|---|---|
| 0 | Interleukin-4 Receptor alpha Antagonist [EPC] | 10265 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 4585 |
| 2 | Corticosteroid [EPC] | 3460 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 2326 |
| 4 | Interleukin-23 Antagonist [EPC] | 1561 |
| 5 | Acetylcholine Release Inhibitor [EPC] | 1466 |
| 6 | Neuromuscular Blocker [EPC] | 1466 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 1281 |
| 8 | Interleukin-17A Antagonist [EPC] | 1235 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 1060 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 200 | 0.2907 |
| 1 | Calcitonin Gene-related Peptide Antagonist [EPC] | 602 | 0.0617 |
| 2 | Catechol-O-Methyltransferase Inhibitor [EPC] | 196 | 0.0389 |
| 3 | Neonatal Fc Receptor Blocker [EPC] | 154 | 0.0351 |
| 4 | Adrenocorticotropic Hormone [EPC] | 31 | 0.0346 |
| 5 | Interleukin-17A Antagonist [EPC] | 1235 | 0.0331 |
| 6 | Provitamin D2 Compound [EPC] | 965 | 0.0324 |
| 7 | Guanylate Cyclase-C Agonist [EPC] | 56 | 0.0270 |
| 8 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 154 | 0.0221 |
| 9 | Interleukin-4 Receptor alpha Antagonist [EPC] | 10265 | 0.0198 |